share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Matsuda Masaru

SEC announcement ·  Mar 6 17:20
Summary by Moomoo AI
Matsuda Masaru, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 3,760 shares of common stock on March 4, 2024. The transaction was executed in the open market at a price of $11.1212 per share, resulting in a total sale value of approximately $41,815.71. Following the sale, Matsuda Masaru's direct holdings in the company amount to 190,424 shares of common stock.
Matsuda Masaru, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 3,760 shares of common stock on March 4, 2024. The transaction was executed in the open market at a price of $11.1212 per share, resulting in a total sale value of approximately $41,815.71. Following the sale, Matsuda Masaru's direct holdings in the company amount to 190,424 shares of common stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more